Kronox Lab Sciences enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024


723	—	—	—
2.7	2.7	3.0	2.6
1.6	1.6	0.0	0.0
721	—	—	—
−1.1	−1.1	−3.0	−2.6
₹194.42	—	—	—

118	118	90.1	66.3
1.4%	1.4%	0.0%	0.0%
0.00×	—	—	—

6.85×	—	—	—
20.50×	—	—	—
21.80×	—	—	—
35.04×	—	—	—
105	101	100	89.9
35.2	34.3	33.1	28.3
33.1	32.2	31.7	27.0
—	23.9	32.5	17.4
20.6	20.6	29.4	5.1
—	20.6	29.4	5.1
—	3.3	3.1	12.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KRONOX₹194.73

Kronox Lab Sciences Limited

· Chemicals

₹ CrorePeersJAYAGROGN DMCC SRHHYPOLTD CHEMFAB PRIMO PLASTIBLEN GEMAROMA SUDARCOLORMcap ₹723 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	722.5
- Cash, Equiv & ST Investments	2.6	3.0	2.7	2.7
+ Total Debt	0.0	0.0	1.6	1.6
Enterprise Value	—	—	—	721.4
Net Debt (memo)	-2.6	-3.0	-1.1	-1.1
EV per Share	—	—	—	194.42

Total Capital	66.3	90.1	117.7	117.7
Total Debt/Total Capital	0.00	0.00	1.36	1.36
Total Debt/EV	—	—	—	0.00

EV/Sales	—	—	—	6.85
EV/EBITDA	—	—	—	20.50
EV/EBIT	—	—	—	21.80
EV/Free Cash Flow	—	—	—	35.04
Reference Items — Trailing FY Values
Sales	89.9	100.2	101.2	105.3
EBITDA	28.3	33.1	34.3	35.2
EBIT	27.0	31.7	32.2	33.1
Operating Cash Flow	17.4	32.5	23.9	—
Free Cash Flow	5.1	29.4	20.6	20.6
FCFF (free cash flow to the firm)	5.1	29.4	20.6	—
Capital Expenditure	12.3	3.1	3.3	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.